OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SNXS57

Synectics PLC

Business Support ServicesVerified

Synectics maintains a fully diluted share count of 17,794,439 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided for comparison. The company's performance relative to the Business Support Services industry remains indeterminate without access to profitability data or cohort medians. Segment and geographic exposure data are not disclosed in the available financial snapshot. The company's revenue concentration and geographic diversification remain opaque without further segment reporting. Growth trajectory is not quantified in the outlook, and no numeric deltas are provided for the current or next fiscal year. Analysts have issued a single "Buy" recommendation with a mean price target of 310.00 GBP, but no consensus on growth expectations is available. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. The company is flagged for liquidity risk, but no further details are available. Dilution risk is assessed as low, with no near-term pressure expected. Recent events and filings are not detailed in the input data. No transcripts or disclosures are available to inform recent operational or strategic developments.

30-day price · SNX+77.52 (+50.7%)
Low$148.19High$242.49Close$230.29As of15 May, 00:00 UTC
Profile
CompanySynectics PLC
TickerSNXS.L
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Services
AI analysis

Business. Synectics PLC provides industrial services, primarily focused on the design, development, and integration of electronic systems and components for defense and aerospace applications.

Classification. Synectics is classified under the Business Support Services industry within the Industrials economic sector, with a confidence level of 0.92.

Synectics maintains a fully diluted share count of 17,794,439 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided for comparison. The company's performance relative to the Business Support Services industry remains indeterminate without access to profitability data or cohort medians. Segment and geographic exposure data are not disclosed in the available financial snapshot. The company's revenue concentration and geographic diversification remain opaque without further segment reporting. Growth trajectory is not quantified in the outlook, and no numeric deltas are provided for the current or next fiscal year. Analysts have issued a single "Buy" recommendation with a mean price target of 310.00 GBP, but no consensus on growth expectations is available. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. The company is flagged for liquidity risk, but no further details are available. Dilution risk is assessed as low, with no near-term pressure expected. Recent events and filings are not detailed in the input data. No transcripts or disclosures are available to inform recent operational or strategic developments.
Key takeaways
  • Synectics operates in the Business Support Services industry, providing electronic systems and components for defense and aerospace.
  • The company has no dilution risk from stock options or convertible instruments.
  • Analysts have issued a single "Buy" recommendation with a mean price target of 310.00 GBP.
  • Liquidity risk could not be assessed due to missing balance-sheet data.
  • No growth trajectory or numeric outlook is provided for the current or next fiscal year.
  • Revenue concentration and geographic exposure remain undisclosed.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$36.6M-$454.0k-$479.0k$719.0k
FY-3$39.1M$494.0k$1.5M$2.3M
FY-2$49.1M$2.8M$2.2M$2.2M
FY-1$55.8M$4.3M$3.2M$1.8M
FY0$68.1M$5.3M$3.7M$2.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$54.1M$35.3M
FY-3$52.4M$37.0M
FY-2$57.6M$38.9M
FY-1$65.8M$41.3M
FY0$64.8M$43.7M
PeriodOCFCapExFCFSBC
FY-4-$607.0k-$875.0k$719.0k
FY-3$1.2M-$314.0k$2.3M
FY-2$3.0M-$1.4M$2.2M
FY-1$8.5M-$1.9M$1.8M
FY0$9.1M-$2.2M$2.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Industrial Services · cohort 626 companies
MetricSNXSActivity
Op margin6.0% medp25 -2.1% · p75 13.4%
Net margin4.1% medp25 -2.2% · p75 10.8%
Gross margin28.8% medp25 19.4% · p75 44.6%
R&D / revenue2.7% medp25 2.4% · p75 3.1%
CapEx / revenue-5.0% medp25 -12.8% · p75 -1.9%
Debt / equity26.4% medp25 5.2% · p75 66.7%
Observations
IR observations
Mean price target310.00 GBP
Median price target310.00 GBP
High price target310.00 GBP
Low price target310.00 GBP
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.09 GBP
Last actual EPS0.28 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:24 UTC#8ecd33f6
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 12:24 UTCJob: 8d7a6c20